Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-12 09:58:50 UTC |
---|
Updated at | 2022-09-12 09:58:50 UTC |
---|
NP-MRD ID | NP0327419 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 2-(16-{[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaene-15-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid |
---|
Description | 2-(15-{[1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]Heptadeca-1(17),2(7),3,5,9,11,13,15-octaene-16-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid belongs to the class of organic compounds known as benzoxanthenes. These are organic compounds containing a benzene ring fused to a xanthene ring system. Xanthene is a tricyclic compound made up of two benzene rings linearly fused to each other through a pyran ring. 2-(16-{[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaene-15-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid is found in Salvia yunnanensis. It was first documented in 2022 (PMID: 36130844). Based on a literature review a significant number of articles have been published on 2-(15-{[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]Heptadeca-1(17),2(7),3,5,9,11,13,15-octaene-16-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid (PMID: 36130843) (PMID: 36130842) (PMID: 36130841) (PMID: 36130840). |
---|
Structure | OC(=O)C(CC1=CC=C(O)C(O)=C1)OC(=O)C1=C(C(=O)OC(CC2=CC=C(O)C(O)=C2)C(O)=O)C2=C3C(C=CC(O)=C3OC3=C(O)C(O)=CC=C23)=C1 InChI=1S/C36H26O16/c37-19-5-1-14(9-23(19)41)11-25(33(44)45)50-35(48)18-13-16-3-7-22(40)32-27(16)28(17-4-8-21(39)30(43)31(17)52-32)29(18)36(49)51-26(34(46)47)12-15-2-6-20(38)24(42)10-15/h1-10,13,25-26,37-43H,11-12H2,(H,44,45)(H,46,47) |
---|
Synonyms | Value | Source |
---|
2-(15-{[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0,.0,]heptadeca-1(17),2(7),3,5,9,11,13,15-octaene-16-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoate | Generator |
|
---|
Chemical Formula | C36H26O16 |
---|
Average Mass | 714.5880 Da |
---|
Monoisotopic Mass | 714.12208 Da |
---|
IUPAC Name | 2-(16-{[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,9,11,13,15-octaene-15-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid |
---|
Traditional Name | 2-(16-{[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl}-5,6,10-trihydroxy-8-oxatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,9,11,13,15-octaene-15-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(=O)C(CC1=CC=C(O)C(O)=C1)OC(=O)C1=C(C(=O)OC(CC2=CC=C(O)C(O)=C2)C(O)=O)C2=C3C(C=CC(O)=C3OC3=C(O)C(O)=CC=C23)=C1 |
---|
InChI Identifier | InChI=1S/C36H26O16/c37-19-5-1-14(9-23(19)41)11-25(33(44)45)50-35(48)18-13-16-3-7-22(40)32-27(16)28(17-4-8-21(39)30(43)31(17)52-32)29(18)36(49)51-26(34(46)47)12-15-2-6-20(38)24(42)10-15/h1-10,13,25-26,37-43H,11-12H2,(H,44,45)(H,46,47) |
---|
InChI Key | KDBFWXTWFOMXHD-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzoxanthenes. These are organic compounds containing a benzene ring fused to a xanthene ring system. Xanthene is a tricyclic compound made up of two benzene rings linearly fused to each other through a pyran ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzopyrans |
---|
Sub Class | 1-benzopyrans |
---|
Direct Parent | Benzoxanthenes |
---|
Alternative Parents | |
---|
Substituents | - Benzoxanthene
- 2-naphthalenecarboxylic acid
- 2-naphthalenecarboxylic acid or derivatives
- Tetracarboxylic acid or derivatives
- 2-naphthol
- 3-phenylpropanoic-acid
- Naphthalene
- 2-benzopyran
- Catechol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Monocyclic benzene moiety
- Benzenoid
- Heteroaromatic compound
- Carboxylic acid ester
- Carboxylic acid
- Carboxylic acid derivative
- Polyol
- Oxacycle
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Cani I, Righini M, Cenni P, Foschi M: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome. Neurology. 2022 Sep 21. pii: WNL.0000000000201378. doi: 10.1212/WNL.0000000000201378. [PubMed:36130844 ]
- Sasaki R, Morimoto S, Ozawa F, Okano H, Yoshida M, Ishiura H, Tsuji S, Kuzuhara S, Kokubo Y: APOE Alleles With Tau and Abeta Pathology In Patients With Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex in the Kii Peninsula. Neurology. 2022 Sep 21. pii: WNL.0000000000201156. doi: 10.1212/WNL.0000000000201156. [PubMed:36130843 ]
- Zhang Z, Wang M, Gill D, Liu X: Genetically Predicted Smoking and Alcohol Consumption and Functional Outcome After Ischemic Stroke. Neurology. 2022 Sep 21. pii: WNL.0000000000201291. doi: 10.1212/WNL.0000000000201291. [PubMed:36130842 ]
- Khamis S, Mitakidou MR, Champion M, Goyal S, Jones RL, Siddiqui A, Sabanathan S, Hedderly T, Lin JP, Jungbluth H, Papandreou A: Clinical Reasoning: A Teenage Girl With Progressive Hyperkinetic Movements, Seizures, and Encephalopathy. Neurology. 2022 Sep 21. pii: WNL.0000000000201385. doi: 10.1212/WNL.0000000000201385. [PubMed:36130841 ]
- Rosenberg A, Ohlund-Wistbacka U, Hall A, Bonnard A, Hagman G, Ryden M, Thunborg C, Wiggenraad F, Sandebring-Matton A, Solomon A, Kivipelto M: beta-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population. Neurology. 2022 Sep 21. pii: WNL.0000000000201043. doi: 10.1212/WNL.0000000000201043. [PubMed:36130840 ]
- LOTUS database [Link]
|
---|